Susisiekti su mumis

Ligos

Komisija ir 35 šalys partnerės nustato € 100 milijoną partnerių, siekdami paskatinti mokslinius tyrimus #RareDiseases

Dalintis:

paskelbta

on

Mes naudojame jūsų registraciją, kad pateiktume turinį jūsų sutiktais būdais ir pagerintume jūsų supratimą. Prenumeratą galite bet kada atšaukti.

As another manifestation of a Europe that apsaugo its citizens, the Commission and 35 partner countries have established a new research partnership on rare diseases. The partnership will give millions of Europeans suffering from one of the many rare diseases a new hope for improved diagnostics and better treatments and care.

With a budget of over €100 million, half of which will come from the EU's research and innovation funding programme Horizon 2020 and half from the partner countries, the new European Joint Programme on Rare Diseases will aim to make sure that new treatments and diagnostic tools reach those who need them the most.

Research, Science and Innovation Commissioner Carlos Moedas said: “Patients with a rare disease often suffer unnecessarily and die prematurely. We need to do much more to develop effective treatments and improve diagnosis. This partnership shows how we can pool Horizon 2020 funding and resources from EU member states and beyond in order to save lives and protect people.”

The partnership comprises more than 130 entities from 35 countries and will be co-ordinated by the French National Institute of Health and Medical Research INSERM. The partnership will be officially launched on 1 January 2019 and will run over five years. More information can be found in a įspėjimas apie naujienas ir informaciniame biuletenyje

Pasidalinkite šiuo straipsniu:

EU Reporter publikuoja straipsnius iš įvairių išorinių šaltinių, kuriuose išreiškiamas platus požiūrių spektras. Šiuose straipsniuose pateiktos pozicijos nebūtinai yra ES Reporterio pozicijos.

Trendai